137 related articles for article (PubMed ID: 22396475)
1. Differentiation and visualization of diverse cellular phenotypic responses in primary high-content screening.
Kümmel A; Selzer P; Siebert D; Schmidt I; Reinhardt J; Götte M; Ibig-Rehm Y; Parker CN; Gabriel D
J Biomol Screen; 2012 Jul; 17(6):843-9. PubMed ID: 22396475
[TBL] [Abstract][Full Text] [Related]
2. Automated image analysis for high-content screening and analysis.
Shariff A; Kangas J; Coelho LP; Quinn S; Murphy RF
J Biomol Screen; 2010 Aug; 15(7):726-34. PubMed ID: 20488979
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening of libraries of compounds to identify CFTR modulators.
Pedemonte N; Zegarra-Moran O; Galietta LJ
Methods Mol Biol; 2011; 741():13-21. PubMed ID: 21594775
[TBL] [Abstract][Full Text] [Related]
4. Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.
Towne DL; Nicholl EE; Comess KM; Galasinski SC; Hajduk PJ; Abraham VC
J Biomol Screen; 2012 Sep; 17(8):1005-17. PubMed ID: 22706350
[TBL] [Abstract][Full Text] [Related]
5. Benchmarking of multivariate similarity measures for high-content screening fingerprints in phenotypic drug discovery.
Reisen F; Zhang X; Gabriel D; Selzer P
J Biomol Screen; 2013 Dec; 18(10):1284-97. PubMed ID: 24045583
[TBL] [Abstract][Full Text] [Related]
6. Systematic approaches to dissect biological processes in stem cells by image-based screening.
Erdmann G; Volz C; Boutros M
Biotechnol J; 2012 Jun; 7(6):768-78. PubMed ID: 22653826
[TBL] [Abstract][Full Text] [Related]
7. A personal perspective on high-content screening (HCS): from the beginning.
Taylor DL
J Biomol Screen; 2010 Aug; 15(7):720-5. PubMed ID: 20639498
[TBL] [Abstract][Full Text] [Related]
8. A novel high-throughput cellular screening assay for the discovery of HIV-1 integrase inhibitors.
Van Loock M; Meersseman G; Van Acker K; Van Den Eynde C; Jochmans D; Van Schoubroeck B; Dams G; Heyndrickx L; Clayton RF
J Virol Methods; 2012 Feb; 179(2):396-401. PubMed ID: 22172974
[TBL] [Abstract][Full Text] [Related]
9. Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness.
Azegrouz H; Karemore G; Torres A; Alaíz CM; Gonzalez AM; Nevado P; Salmerón A; Pellinen T; del Pozo MA; Dorronsoro JR; Montoya MC
J Biomol Screen; 2013 Dec; 18(10):1270-83. PubMed ID: 24045580
[TBL] [Abstract][Full Text] [Related]
10. High-content screening. Introduction.
Trask OJ; Davies A; Haney S
J Biomol Screen; 2010 Aug; 15(7):719. PubMed ID: 20729342
[No Abstract] [Full Text] [Related]
11. Image analysis benchmarking methods for high-content screen design.
Fuller CJ; Straight AF
J Microsc; 2010 May; 238(2):145-61. PubMed ID: 20529062
[TBL] [Abstract][Full Text] [Related]
12. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
Hampton SL; Kinnaird AI
Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
[TBL] [Abstract][Full Text] [Related]
13. High-content analysis to leverage a robust phenotypic profiling approach to vascular modulation.
Isherwood BJ; Walls RE; Roberts ME; Houslay TM; Brave SR; Barry ST; Carragher NO
J Biomol Screen; 2013 Dec; 18(10):1246-59. PubMed ID: 24108119
[TBL] [Abstract][Full Text] [Related]
14. AlphaScreen-based characterization of the bifunctional kinase/RNase IRE1alpha: a novel and atypical drug target.
Bouchecareilh M; Caruso ME; Roby P; Parent S; Rouleau N; Taouji S; Pluquet O; Bossé R; Moenner M; Chevet E
J Biomol Screen; 2010 Apr; 15(4):406-17. PubMed ID: 20237204
[TBL] [Abstract][Full Text] [Related]
15. High content screening: seeing is believing.
Zanella F; Lorens JB; Link W
Trends Biotechnol; 2010 May; 28(5):237-45. PubMed ID: 20346526
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profiling of chemokine receptor-directed compounds using high-content screening.
Haasen D; Merk S; Seither P; Martyres D; Hobbie S; Heilker R
J Biomol Screen; 2008 Jan; 13(1):40-53. PubMed ID: 18227225
[TBL] [Abstract][Full Text] [Related]
17. Automated laser scanning cytometry: a powerful tool for multi-parameter analysis of drug-induced apoptosis.
Holme AL; Yadav SK; Pervaiz S
Cytometry A; 2007 Feb; 71(2):80-6. PubMed ID: 17200953
[TBL] [Abstract][Full Text] [Related]
18. Quantifying amyloid beta (Aβ)-mediated changes in neuronal morphology in primary cultures: implications for phenotypic screening.
Nguyen L; Wright S; Lee M; Ren Z; Sauer JM; Hoffman W; Zago W; Kinney GG; Bova MP
J Biomol Screen; 2012 Jul; 17(6):835-42. PubMed ID: 22473881
[TBL] [Abstract][Full Text] [Related]
19. DetecTiff: a novel image analysis routine for high-content screening microscopy.
Gilbert DF; Meinhof T; Pepperkok R; Runz H
J Biomol Screen; 2009 Sep; 14(8):944-55. PubMed ID: 19641223
[TBL] [Abstract][Full Text] [Related]
20. High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay.
Liu K; Samuel M; Tillett J; Hennan JK; Mekonnen B; Soloveva V; Harrison RK; Paslay JW; Larocque J
J Biomol Screen; 2010 Feb; 15(2):185-95. PubMed ID: 20044579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
